bpc-157 human clinical trials evidence fda warning and the Difference Between an Gap and a Cover-Up: What the entire evidence base actually looks like, and the questions to ask next. — WellFounded The Hidden Risks of BPC‑157:
Description
In vitro assessment of copper-induced toxicity in the human hepatoma line, Hep G2
Redness, swelling, itching, or tenderness at the injection site occurs in some users, particularly during the first few weeks as the immune system adjusts
Gastric emptying was measured by determining the percentage of total recovered radioactivity remaining in the stomach 15 minutes after intragastric gavage of a specific substance
Measure the powder according to your desired concentration
Regulatory bodies (the FDA and EMA) classify BPC-157 as a research compound, reflecting the absence of verified human safety data
